HSD16 PCSK-9 Inhibitors for the Control of Hypercholesterolemia: Eligibility for Treatment, Prescription Appropriateness and Outcomes, in a Real-World Clinical Setting
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1360
https://www.valueinhealthjournal.com/article/S1098-3015(22)03565-3/fulltext
Title :
HSD16 PCSK-9 Inhibitors for the Control of Hypercholesterolemia: Eligibility for Treatment, Prescription Appropriateness and Outcomes, in a Real-World Clinical Setting
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03565-3&doi=10.1016/j.jval.2022.09.1360
First page :
Section Title :
Open access? :
No
Section Order :
10904